ATE420633T1 - Zusammensetzung und ihre verwendung zur behandlung von neuropathischem verlust der sensibilität - Google Patents

Zusammensetzung und ihre verwendung zur behandlung von neuropathischem verlust der sensibilität

Info

Publication number
ATE420633T1
ATE420633T1 AT03796465T AT03796465T ATE420633T1 AT E420633 T1 ATE420633 T1 AT E420633T1 AT 03796465 T AT03796465 T AT 03796465T AT 03796465 T AT03796465 T AT 03796465T AT E420633 T1 ATE420633 T1 AT E420633T1
Authority
AT
Austria
Prior art keywords
nsp
anesthetic
neuropathic
sensitivity
loss
Prior art date
Application number
AT03796465T
Other languages
English (en)
Inventor
Bradley Galer
Arnold Gammaitoni
Robert Dworkin
Original Assignee
Endo Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endo Pharmaceuticals Inc filed Critical Endo Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE420633T1 publication Critical patent/ATE420633T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT03796465T 2002-11-26 2003-11-25 Zusammensetzung und ihre verwendung zur behandlung von neuropathischem verlust der sensibilität ATE420633T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42920802P 2002-11-26 2002-11-26

Publications (1)

Publication Number Publication Date
ATE420633T1 true ATE420633T1 (de) 2009-01-15

Family

ID=32393523

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03796465T ATE420633T1 (de) 2002-11-26 2003-11-25 Zusammensetzung und ihre verwendung zur behandlung von neuropathischem verlust der sensibilität

Country Status (9)

Country Link
EP (1) EP1565173B1 (de)
JP (1) JP2006509766A (de)
CN (1) CN1717229A (de)
AT (1) ATE420633T1 (de)
AU (1) AU2003298710B2 (de)
CA (1) CA2507217C (de)
DE (1) DE60325885D1 (de)
ES (1) ES2319764T3 (de)
WO (1) WO2004047819A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006036936A2 (en) 2004-09-27 2006-04-06 Bridge Pharma, Inc. The s-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents
WO2008011161A2 (en) 2006-07-21 2008-01-24 Bridge Pharma, Inc. Dermal anesthetic compounds
EP2326323A4 (de) * 2008-08-13 2012-02-22 Neuroquest Inc Zusammensetzungen mit terpenverbindungen zur behandlung negativer sensorischer phänomene
NZ591834A (en) 2008-10-02 2011-12-22 Mylan Inc Method of making a multilayer adhesive laminate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5993018A (ja) * 1982-11-18 1984-05-29 Sumitomo Chem Co Ltd 顔面錯感覚症治療薬
US5234957A (en) * 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents

Also Published As

Publication number Publication date
CA2507217A1 (en) 2004-06-10
ES2319764T3 (es) 2009-05-12
DE60325885D1 (de) 2009-03-05
AU2003298710A1 (en) 2004-06-18
EP1565173A2 (de) 2005-08-24
WO2004047819A2 (en) 2004-06-10
JP2006509766A (ja) 2006-03-23
AU2003298710B2 (en) 2008-02-07
WO2004047819A3 (en) 2004-07-29
CN1717229A (zh) 2006-01-04
CA2507217C (en) 2012-08-28
EP1565173B1 (de) 2009-01-14

Similar Documents

Publication Publication Date Title
ATE468137T1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
ATE276749T1 (de) Zusammensetzungen zur vorbeugung und behandlung der erkältung und grippe-artiger symptome und ihre verwendung
ATE462427T1 (de) Verwendung von treprostinil zur behandlung von neuropathischen diabetischen fussgeschwüren
NO20093464L (no) Nye medikamentblandinger basert pa anti-cholinergisk effektive forbindelser og beta-mimetika
IS8058A (is) Sýklísk súlfónamíð til að hamla gamma seytiasa
DE69213814D1 (de) Melatoninderivate zur Behandlung von Schlafstörungen und zur Pre-Anästhesie
DE59409312D1 (de) Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten
DE60037394D1 (de) VERWENDUNG VON p53 INHIBITOREN ZUR BEHANDLUNG VON NEBENERSCHEINUNGEN BEI DER KREBSTHERAPIE
DE69428791D1 (de) Verwendung vonModafinil zur Behandlung von Atemstillstand im Schlaf und zentral erregten Atembeschwerden
ATE346614T1 (de) Vaginale zusammensetzung enthaltend lidocaine zur behandlung von gebärmutterrhythmusstörung
ATE452642T1 (de) Verwendung von cox-2 inhibitoren zur behandlung von affectiven störungen
DE60221283D1 (de) Verwendung von oxindolderivaten zur behandlung von mit demenz in zusammenhang stehenden krankheiten, alzheimer-krankheit und mit glycogensynthasekinase-3 assoziierten leiden
SE0102147D0 (sv) New methods
ATE472329T1 (de) Verwendung der kombination von ciclesonid und antihistaminika zur behandlung von allergischer rhinitis
ATE420633T1 (de) Zusammensetzung und ihre verwendung zur behandlung von neuropathischem verlust der sensibilität
DE60224004D1 (de) Verwendung von il-18 hemmern zur behandlung und/oder prävention von herzkrankheiten
DE50205814D1 (de) Verwendung von mittelkettigen Triglyceriden zur Prävention und Therapie von Adipositas
ATE400277T1 (de) Pharmazeutische zusammenstellung zur vorbeugung und behandlung von mit zellkrankheiten des augenhintergrundes zusammenhängenden krankheiten
ATE542542T1 (de) Verwendung von gp130 aktivatoren zur behandlung von diabetischer neuropathie
ATE375152T1 (de) Behandlung von gastrointestinalen erkrankungen mit n-2,3,3-tetramethylbicyclo[2.2.1]heptan-2- amine
ATE404203T1 (de) Verwendung von desoxypeganin zur behandlung der klinischen depression
ATE287400T1 (de) 4-(phenylpiperidin-4-ylidenmethyl) benzamidderivate und deren verwendung zur behandlung von schmerzen, angst oder gastrointestinalen störungen
DE602004012770D1 (de) Saure chinolin-derivate und ihre verwendung zur prävention und/oder behandlung von erkrankungen im zusammenhang mit hyperglykämie
ATE313528T1 (de) 4-(phenyl(piperidin-4-yl)amino) benzamidderivate und deren verwendung zur behandlung von schmerzen,angst oder gastrointestinalen störungen
ATE407925T1 (de) 1,4-dihydropyridinverbindungen, pharmazeutische verbindungen, und verfahren zur behandlung von herzkreislauferkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties